Home › Researcher directory › Eleni Efstathiou

Eleni Efstathiou

Affiliation : Houston Methodist

• 9Publications (affiliation in the United States)
• 408Total publications
• 22426Citations
• 63h-index

ORCIDOpenAlex

Research profile

Eleni Efstathiou has 9 indexed publications (2012–2024). Their work appears mainly in “European Urology”, “European Journal of Cancer” and “Annals of Oncology”. Their most cited article, “Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019” (2020), has been cited 390 times. 6 of these publications date from the last three years of activity. Their work is co-authored with at least 12 researchers, including institutions in United Kingdom, Switzerland, Hong Kong, Italy.

Is this you? Get your research seen

Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.

Create my free profile Add my publications

Research areas

• Prostate Cancer Treatment and Research
• Prostate Cancer Diagnosis and Treatment
• Bone health and treatments
• Cancer Genomics and Diagnostics
• Breast Cancer Treatment Studies

Publications (9)

• Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)
  2024 · European Urology · cited 141 times
• Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
  2023 · European Journal of Cancer · cited 169 times
• Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021
  2022 · European Urology · cited 130 times
• Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
  2022 · European Urology · cited 122 times
• What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021
  2022 · European Urology · cited 9 times
• Corrigendum to “What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021” [Eur Urol 82(1):6–11]
  2022 · European Urology
• Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
  2020 · European Urology · cited 390 times
• Efficacy and Tolerability of Taxane-Based Chemotherapy in Senior Adults with Metastatic Castration-Resistant Prostate Cancer (MCRPC): A Prospective International Registry
  2012 · Annals of Oncology
• Taxane-based chemotherapy in senior adults with metastatic castration-resistant prostate cancer (mCRPC): A prospective international registry.
  2012 · Journal of Clinical Oncology

Publication venues

• European Urology × 6
• European Journal of Cancer × 1
• Annals of Oncology × 1
• Journal of Clinical Oncology × 1

Publications per year

• 20241
• 20231
• 20224
• 20201
• 20122

Collaborations

Partner institutions : Istituto Oncologico della Svizzera Italiana · Ospedale Santa Chiara · Institute of Cancer Research · University of Washington · Memorial Sloan Kettering Cancer Center

Co-authors’ countries : United Kingdom · Switzerland · Hong Kong · Italy

Co-authors

• Neal D. Shore
• Robert Evan Reiter
• William K. Oh
• Howard I. Scher
• Susan Halabi
• Himisha Beltran
• Felix Yi-Chung Feng
• Michael J. Morris
• Charles J. Ryan
• Eric Jay Small
• Alicia Katherine Morgans
• Howard R. Soule

Bibliographic data from OpenAlex (open database).